Agenda

Download 2021 Brochure
Flip through our 2021 conference brochure and discover what’s new this year.
- Jump to:
- At a Glance
- Day 1
- Print-friendly Format
Day 1
Day 1
10:00 |
Opening Remarks from the Conference Co-Chairs![]() Mariana Kurlat ![]() Jennifer H. Saperstein |
10:15 |
FCPA Enforcement in the Life Sciences Arena:Emerging Liability Risks and New Enforcement Priorities Amid Covid-19![]() David Last ![]() Robert I. Dodge ![]() Bernard J. Cooney Hear from an esteemed panel of DOJ and SEC representatives on key topics, including:
|
11:00 |
INTERACTIVE DISCUSSION – AUDIENCE POLLINGThe Newest, Unwritten Rules for Third Party Due Diligence: How to Resolve the Most Industry-Specific Dilemmas![]() Kathleen M. Hamann ![]() Jill Dailey ![]() Nancy S. Travis With over 90% of FCPA enforcement actions involving third parties, ensuring adequate oversight of distributors and foreign subsidiaries continues to be a critical concern for life sciences companies. Test your knowledge on the most vexing grey areas of third party due diligence. You will engage in 2 hypothetical exercises – participate in anonymous polling or turn on your audio and video to share your perspective with fellow participants. PART I: SUB-DISTRIBUTORS
PART II: FOREIGN SUBSIDIARIES
|
12:00 |
Break |
12:30 |
SPECIAL INTERVIEW WITH NOVARTISReflecting on the 2020 Settlement and a Reimagined Approach to Ethics & Compliance![]() Robert N. Sikellis ![]() Marc Hennes ![]() James M. Koukios
|
1:00 |
Digital Transformation for Anti-Corruption: Leveraging Data Analytics, Automation and Machine Learning to Prevent and Detect FCPA Violations![]() Ash Aggarwal ![]() Parth Chanda ![]() Kate Kiesel
|
1:45 |
1:1 Peer-to-Peer Networking |
2:00 |
Break |
2:15 |
JOIN THE CONVERSATIONHow to Measure the Effectiveness of Your Compliance Program: Industry-Specific Considerations![]() Joseph Mack ![]() Mona Peterson Rosow ![]() William Simmons Moderator:![]() David H. Resnicoff
Turn on your audio and video during the latter part of the session to chat, compare notes, and share “war stories” with the speakers and fellow participants! |
3:30 |
PUBLIC PROCUREMENTEngaging with Foreign Governments and Providers Amid Covid-19: Special Considerations for the Sale of Medical Supplies and Vaccine Procurement![]() Derek A. Cohen ![]() Megan Gordon The global pandemic has triggered unprecedented levels of negotiation with foreign governments. From Covid testing products to personal protective equipment, therapeutics, and vaccines, lack of access and critical need for these products creates fertile ground for bribery and corruption around the world. This session will address:
|
4:15 |
Break |
4:30 |
SPOTLIGHT ON CLINICAL TRIALSDetermining When (and When Not) to Proceed with Clinical Trials Abroad: Managing Unique, Evolving Bribery Risk Factors![]() Jessica S. Pill ![]() William B.F. Steinman
|
5:15 |
TEST YOUR KNOWLEDGE: AUDIENCE POLLINGThe Nuances of Sponsorship, Hospitality, and Advisory Board Membership of Foreign Healthcare Providers: What Companies are Now Doing to Strengthen Compliance![]() Peter G. Jensen ![]() Patrick F. Stokes Respond to panel questions confidentially in a user-friendly digital polling system. An effective way to compare your compliance and investigations practices to your peers across the globe!
|
6:00 |
Conference Concludes |